* already on chronic statin therapy, known hypersensitivity or adverse events to statins, negative nasopharyngeal (np) swab for sars-cov-2, pregnancy and lactation, need for icu admission, alt or ast \>2x upper limit of normal; cpk \> 5x upper limit of normal; and creatinine clearance \<50%, chronic treatment with colchicine, cyclosporin, digoxin, fusidic acid, azole antifungals, niacin.

* already on chronic statin therapy, known hypersensitivity or adverse events to statins, negative nasopharyngeal (np) swab for sars-cov-2, pregnancy and lactation, need for icu admission, alt or ast \>2x upper limit of normal; cpk \> 5x upper limit of normal; and creatinine clearance \<50%, chronic treatment with colchicine, cyclosporin, digoxin, fusidic acid, azole antifungals, niacin.

- already on chronic statin therapy, known hypersensitivity or adverse events to statins, negative nasopharyngeal (np) swab for sars-cov-2, pregnancy and lactation, need for icu admission, alt or ast >2x upper limit of normal; cpk > 5x upper limit of normal; and creatinine clearance <50%, chronic treatment with colchicine, cyclosporin, digoxin, fusidic acid, azole antifungals, niacin.

- already on chronic statin therapy, known hypersensitivity or adverse events to statins, negative nasopharyngeal (np) swab for sars-cov-2, pregnancy and lactation, need for icu admission, alt or ast >2x upper limit of normal; cpk > 5x upper limit of normal; and creatinine clearance <50%, chronic treatment with colchicine, cyclosporin, digoxin, fusidic acid, azole antifungals, niacin.